The number of hot flashes was significantly lower in the Hop group than the control group during the weeks 4 (-8.4, -9.8--7.1), 8 (-17.1, -14.9--19.3) and 12 (-23.8, -21.1--26.4). CONCLUSIONS: Hop effectively reduced the early menopausal symptoms. CLINICAL TRIAL REGISTRATION: This study was approved (code 91209) by the Ethic Committee of Tabriz university of Medical Sciences and registered at the Iranian registry of clinical trials, with IRCT 2013010110324N7 on April 2013. 